Harel Insurance Investments & Financial Services Ltd. Vista Gen Therapeutics, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.31 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Jul 26, 2021	SELL	$1.96 - $3.15 $392,000 - $630,000	-200,000 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$1.89 - $2.96 $378,000 - $592,000	200,000 New	200,000 $1.42 Million

Others Institutions Holding VTGN

# of Institutions

Shares Held

2.7M

Call Options Held

Put Options Held

Tcg Crossover Management, LLC Palo Alto, CA

2.68M
Shares

$9.45 Million
1.49% of portfolio
Personal Capital Advisors Corp

27.1K
Shares

$95,663
0.0% of portfolio

View Full List

About VistaGen Therapeutics, Inc.

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

More about VTGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account